Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.060
-0.020 (-1.85%)
At close: May 19, 2026, 4:00 PM EDT
1.060
0.00 (0.04%)
After-hours: May 19, 2026, 5:29 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $12.31 million as of May 19, 2026. Its market cap has increased by 31.49% in one year.
Market Cap
12.31M
Enterprise Value
-4.48M
1-Year Change
31.49%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $12.31M, a decrease of -24.08%. That is a compound annual growth rate of -1.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 12.55M | 11.01% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 13.57M |
| Ernexa Therapeutics | 13.35M |
| CEL-SCI | 12.87M |
| Cyclerion Therapeutics | 12.68M |
| Moleculin Biotech | 12.54M |
| BioLineRx | 12.48M |
| Theriva Biologics | 12.25M |
| Intensity Therapeutics | 12.16M |